The End of Opioids? Inside Suzetrigine’s Pain Pill
For more than twenty years, doctors treating serious pain had exactly two real choices: opioids, with all their addiction risk, or medications too weak to touch severe pain. That gap finally closed in January 2025, when the FDA approved suzetrigine — sold under the brand name Journavx — as the first non-opioid pain pill in…